Immuno-Oncology | Specialty

Advanced Bladder Cancer: Predicting Clinical Response

December 28th 2017

Impact of Immunotherapy in Advanced Bladder Cancer

December 28th 2017

Unmet Needs in Ovarian Cancer

December 23rd 2017

Evolving Role of PARP Inhibitors in Ovarian Cancer

December 23rd 2017

PARP Inhibitor Side Effect Management in Ovarian Cancer

December 23rd 2017

Ovarian Cancer: Deciding Among PARP Inhibitors

December 23rd 2017

Ovarian Cancer Decisions: Treatment Versus Maintenance

December 23rd 2017

Talking With Patients About Recurrence Risk in Ovarian Cancer

December 23rd 2017

Ovarian Cancer: Making Treatment Plans Together

December 23rd 2017

Options With Genetic Testing in Ovarian Cancer

December 23rd 2017

Platinum Sensitivity and PARP Inhibition in Ovarian Cancer

December 23rd 2017

Ovarian Cancer: Talking to Patients About PARP Inhibitors

December 23rd 2017

Immunotherapy/RT Combos Could Be Next Wave of Novel Treatment in Lung Cancers

December 22nd 2017

Sagus Sampath, MD, discusses ongoing studies exploring checkpoint inhibitors with radiation therapy and the promise of integrating these 2 treatments in the field of non-small cell lung cancer.

Future of Immunotherapy in Ovarian Cancer to Include Combinations

December 22nd 2017

Bradley J. Monk, MD, discusses pivotal trials, as well as the potential for immunotherapy in ovarian cancer.

Gastric/GEJ Cancers: Looking Toward the Future

December 22nd 2017

The Evolving Treatment Landscape in Gastric/GEJ Cancers

December 22nd 2017

Gastric/GEJ Cancers: Non-Immunotherapeutic Advancements

December 22nd 2017

Other Immunotherapy Approaches in Gastric/GEJ Cancers

December 22nd 2017

Emerging Nivolumab Strategies in Gastric/GEJ Cancers

December 22nd 2017

Practical Considerations for Prescribing Immunotherapy

December 22nd 2017